Concepedia
Statistics
Publications
30
Citations
2K
H-Index
17
Active since
2006
Affiliations
UPMC Hillman Cancer Center(Current)
University of Pittsburgh Medical Center
Universität Hamburg
University Medical Center Hamburg-Eppendorf
The University of Texas MD Anderson Cancer Center
Jing‐Zhou Hou is an author at UPMC Hillman Cancer Center specializing in medicine, chemotherapy, and oncology.
Publications per year
2006–2024
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Andrew H. Wei, Pau Montesinos, Vladimir Ivanov et al. · Blood · 2020 · 756 citations · Full text
Medicine, Oncology, Pharmacology +9
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Robert Zeiser, Dennis B. Leveson-Gower, Elizabeth A. Zambricki et al. · Blood · 2007 · 394 citations · Full text
Life Sciences, Cell Biology, Immunology +17
Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia
Michael Boyiadzis, Mounzer Agha, Robert L. Redner et al. · Cytotherapy · 2017 · 179 citations
Life Sciences, Immunology, Oncology +17
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Robert Zeiser, Vu Nguyen, Jing‐Zhou Hou et al. · Blood · 2006 · 77 citations · Full text
Life Sciences, Immunology, Adaptive Immunity +15
Follicular lymphoma B cells induce the conversion of conventional CD4<sup>+</sup> T cells to T‐regulatory cells
Weiyun Z. Ai, Jing‐Zhou Hou, Robert Zeiser et al. · International Journal of Cancer · 2008 · 73 citations · Full text
Life Sciences, Immunology, Oncology +15
1–5 of 30